The Update on Measuring Ketones webinar will be held on October 13, 2022 from 9 AM to 10:30 AM Pacific Time.
Click here to learn more. Applications are due by August 31, 2022.
Please review the guidelines and submit an application to the Startup Showcase by September 28, 2020.
Please review the guidelines and submit an abstract to Diabetes Technology Meeting 2020 by August 31, 2020.
Join the DTS mailing list
and receive updates
delivered to your inbox.
MEDSCAPE: What Is the Glycemic Risk Index and Why Do We Need It?
UPI: Pacemakers, insulin pumps can be hacked, experts say
HEALIO: Glycemia Risk Index provides new tool for assessing glycemic control with CGM data
HEALIO: Stakeholders challenged to take action at first Green Diabetes Summit
MEDSCAPE: Continuous Ketone Monitoring Has Potential to Cut DKA in Diabetes
DIATRIBE: Glycemia Risk Index – An Emerging Measurement to Complement Your TIR
HEALIO: Connectivity, digital tools becoming the ‘sixth vital sign’ in health care
MEDSCAPE: Wearable Continuous Ketone Monitoring Appears Feasible
HEALIO: Continuous ketone monitoring may provide early identification of DKA
HP ENTERPRISE.NXT: How the edge is reshaping healthcare
MEDSCAPE: Protecting Patients With Diabetes From Impact of COVID-19
ENDOCRINOLOGY ADVISOR: Benefits of Continuous Glucose Monitoring Systems in the Hospital Setting
HEALIO: Telehealth shift during COVID-19 pandemic shows capacity to deliver safe, convenient care
ENDOCRINE NEWS: New App Helps Improve Diabetes Care in Patients with COVID-19
ENDOCRINE NEWS: Pandemic Parallels: Glycemic Control in COVID-19 Patients
MEDSCAPE: Largest Study to Date Links Glucose Control to COVID-19 Outcomes
NEWSDAY: Coronavirus poses special risks for diabetics
HEALIO: Uncontrolled hyperglycemia, diabetes drive longer hospital stay, mortality in COVID-19
ELSEVIER: Diabetes Digital Health (Edited by David Klonoff et al.)
THE WASHINGTON POST: DIY diabetes tech gains popularity with patients and parents fed up with clunky mainstream medical devices
HEALIO: Postoperative infections less frequent with insulin pump therapy for adults with diabetes
THE DIPLOMAT: Cost of Diabetes Reaches $850 Billion a Year Globally
ADA: David Klonoff, MD, President of Diabetes Technology Society, receives an international award from the American Diabetes Association.